Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes
Description
CONCLUSIONS AND RELEVANCE: In this study, nMAb treatment for COVID-19 was safe and associated with reductions in ED visits, hospitalization, and death, although it was not associated with reduced risk of hospitalization during the Omicron BA.1 epoch
